![Charles Osborne](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charles Osborne
Director of Finance/CFO at POLAREAN IMAGING PLC
Charles Osborne active positions
Companies | Position | Start | End |
---|---|---|---|
POLAREAN IMAGING PLC | Director/Board Member | 2021-02-21 | - |
Director of Finance/CFO | 2019-04-28 | - |
Career history of Charles Osborne
Former positions of Charles Osborne
Companies | Position | Start | End |
---|---|---|---|
Innocrin Pharmaceuticals, Inc.
![]() Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Director of Finance/CFO | 2015-07-04 | 2019-03-31 |
Corporate Secretary | 2015-06-30 | 2019-03-31 | |
SCYNEXIS, INC. | Director of Finance/CFO | 2003-10-31 | 2015-06-29 |
International Murex Technologies Corp.
![]() International Murex Technologies Corp. Medical SpecialtiesHealth Technology International Murex Technologies Corp. develops medical diagnostic products. It provides infectious disease screening services. The company is headquartered in Norcross, GA. | Director of Finance/CFO | - | - |
Nobex Corp.
![]() Nobex Corp. Pharmaceuticals: MajorHealth Technology Protein Delivery Inc. is drug delivery company. It specializes in proprietary polymer-based technology for the stabilization and oral delivery of proteins and peptides as well as the delivery of small molecules across the blood-brain barrier. The company's technology also enables the delivery of drugs into the brain to treat diseases of the central nervous system. Protein Delivery is located in Durham, NC | Director of Finance/CFO | - | - |
Training of Charles Osborne
The University of North Carolina at Charlotte | Undergraduate Degree |
Statistics
International
United States | 6 |
United Kingdom | 2 |
Operational
Director of Finance/CFO | 5 |
Undergraduate Degree | 1 |
Corporate Secretary | 1 |
Sectoral
Health Technology | 6 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
SCYNEXIS, INC. | Health Technology |
POLAREAN IMAGING PLC | Health Technology |
Private companies | 3 |
---|---|
Nobex Corp.
![]() Nobex Corp. Pharmaceuticals: MajorHealth Technology Protein Delivery Inc. is drug delivery company. It specializes in proprietary polymer-based technology for the stabilization and oral delivery of proteins and peptides as well as the delivery of small molecules across the blood-brain barrier. The company's technology also enables the delivery of drugs into the brain to treat diseases of the central nervous system. Protein Delivery is located in Durham, NC | Health Technology |
International Murex Technologies Corp.
![]() International Murex Technologies Corp. Medical SpecialtiesHealth Technology International Murex Technologies Corp. develops medical diagnostic products. It provides infectious disease screening services. The company is headquartered in Norcross, GA. | Health Technology |
Innocrin Pharmaceuticals, Inc.
![]() Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Charles Osborne
- Experience